Clinical Trials in Detroit

Showing 15901-15920 of 19,719 trials

A Study Of Oral Palbociclib (PD-0332991), A Cyclin-Dependent Kinase Inhibitor, In Patients With Advanced Cancer

NCT00141297

PD-0332991 may work in cancer by stopping cancer cells from multiplying. PD-0332991 is in a new class of drugs called cyclin-dependent kinase (CDK inhibitors). This research study is the first time that PD-0332991 will be given to people. PD-0332991 is taken by mouth daily.

NeoplasmsLymphoma, Non-Hodgkin

Pfizer74 participantsStarted Sep 2004

Detroit, Michigan, United States • New York, New York, United States • Philadelphia, Pennsylvania, United States +1 more locations

TERMINATEDPhase 312 miles

Efficacy and Safety Study of Gevokizumab to Treat Behcet's Disease Uveitis

NCT02258867

The objective of this study is to assess the efficacy and safety of gevokizumab in treating Behcet's disease uveitis (BDU).

Behcet's Disease Uveitis

XOMA (US) LLC4 participantsStarted Nov 2014

Santa Ana, California, United States • Chicago, Illinois, United States • Ellsworth, Maine, United States +5 more locations

COMPLETEDPhase 220 miles

Safety Study of Apixaban in Recent Acute Coronary Syndrome

NCT00313300

The purpose of this clinical research study is to determine whether apixaban will be safe in people who have recently had unstable angina or a heart attack.

Acute Coronary Syndrome (ACS)

Bristol-Myers Squibb1,741 participantsStarted May 2006

Scottsdale, Arizona, United States • Los Angeles, California, United States • Santa Rosa, California, United States +148 more locations

A Study Of Oral Palbociclib (PD-0332991), A Cyclin-Dependent Kinase Inhibitor, In Patients With Advanced Cancer

Efficacy and Safety Study of Gevokizumab to Treat Behcet's Disease Uveitis

Safety Study of Apixaban in Recent Acute Coronary Syndrome

Find Trials by Condition in Detroit

Riociguat in Patients With Chronic Thromboembolic Pulmonary Hypertension (CTEPH)

A Study to Evaluate the Safety and Effectiveness of CNTO 888 Administered Intravenously (IV) in Participants With Idiopathic Pulmonary Fibrosis (IPF)

Study of Taxane/Carboplatin +/- Cetuximab as First-Line Treatment for Patients With Advanced/Metastatic Non-Small Cell Lung Cancer

Noninvasive Methods to Monitor Graft Survival in Heart Transplant Patients

A Study in Men With Low Testosterone to Measure the Effects of Testosterone Solution on Testosterone Levels, Sex Drive and Energy

Expanded Treatment Prot of Panobinostat in Combo w/ Bortez and Dex in Pts w/ Relapsed and/or Refractory Multiple Myeloma

Celecoxib in Preventing Hand/Foot Syndrome Caused By Capecitabine With Metastatic Breast or Colorectal Cancer

Safety Study of Cetuximab in Combination With Cisplatin and Vinorelbine to Treat Advanced Non-small Cell Lung Cancer

Safety and Antiviral Study of ACH-126, 443 (Beta-L-Fd4C) in the Treatment of Adults With HIV Infection and Modestly Detectable Viral Load.

Efficacy and Safety of Everolimus in Combination Therapy, in Patients With HER2-overexpressing Metastatic Breast Cancer

Guidant Microwave Ablation System for the Treatment of Atrial Fibrillation

Multiple-dose Regimen Study to Assess Effect of 12 Months of Secukinumab Treatment on Skin Response and Biomarkers in Psoriasis Patients

Imexon for Relapsed Follicular and Aggressive Lymphomas

Study of GRN163L With Paclitaxel and Carboplatin in Patients With Advanced or Metastatic Non Small Cell Lung Cancer

Study Evaluating ACC-001 In Subjects With Mild To Moderate Alzheimer's Disease

Study to Evaluate the Effect of Cetuximab on Corrected QT (QTc) Interval Changes in Patients With Advanced Malignancies From Solid Tumors

A Pharmacodynamics Pre-surgical Study of LEE011 in Early Breast Cancer Patients (MONALEESA-1)